⚠ HEALTH CANADA BLACK BOX WARNING
Premature discontinuation increases stroke risk: Stopping Xarelto without adequate alternative anticoagulation significantly increases the risk of ischaemic stroke in patients with non-valvular atrial fibrillation. Do not stop taking rivaroxaban without first consulting your prescribing physician.
Spinal/epidural haematoma risk: Patients receiving neuraxial anaesthesia (epidural or spinal) or undergoing spinal puncture while on rivaroxaban are at risk of epidural or spinal haematoma, which can result in long-term or permanent paralysis. This risk is increased in patients using indwelling epidural catheters or concomitant NSAIDs, platelet inhibitors, or other anticoagulants.
Health Canada-Approved Indications for Rivaroxaban
| Indication | Dose | Duration | Notes |
|---|---|---|---|
| DVT/PE treatment (acute) | 15mg twice daily with food | First 21 days | Then 20mg once daily with food |
| DVT/PE extended prevention | 20mg once daily with food | Ongoing | Or 10mg once daily after ≥6 months of treatment |
| Non-valvular atrial fibrillation (stroke prevention) | 20mg once daily with evening meal | Ongoing (lifelong in most patients) | 15mg once daily if CrCl 15–49 mL/min |
| Post-hip or knee replacement surgery (VTE prophylaxis) | 10mg once daily | 35 days (hip); 12 days (knee) | Begin 6–10 hours post-surgery when haemostasis established |
| Cardiovascular risk reduction (CAD/PAD) with aspirin | 2.5mg twice daily | Ongoing | Combined with aspirin 75–100mg; vascular compass regimen |
Critical: the dose is entirely indication-dependent and must be prescribed by a physician. Taking the wrong dose for your condition — or self-adjusting the dose — carries serious risks of either inadequate clot prevention or dangerous bleeding. Never change your rivaroxaban dose without medical guidance.
How Rivaroxaban Works — Factor Xa Inhibition
To understand rivaroxaban's mechanism, it is helpful to understand the coagulation cascade. Blood clotting is a carefully regulated chain of enzymatic reactions that ultimately converts fibrinogen to fibrin — the mesh that forms a clot. Factor Xa sits at the convergence of both the intrinsic and extrinsic coagulation pathways, making it a highly strategic target:
- Factor Xa is the gatekeeper of thrombin generation: it converts prothrombin to thrombin — the enzyme that converts fibrinogen to fibrin and activates platelets. One molecule of Factor Xa can generate 1,000 molecules of thrombin
- Rivaroxaban binds directly to Factor Xa in a reversible, concentration-dependent manner, blocking its active site and preventing thrombin generation
- No antithrombin III required: unlike heparin, rivaroxaban does not require a cofactor — it works independently, which gives it a more predictable pharmacological profile
- Does not inactivate existing thrombin: rivaroxaban does not directly affect thrombin activity or platelet aggregation — it prevents new clot formation rather than dissolving existing clots
Why rivaroxaban does not require INR monitoring: Warfarin's effect varies with diet (vitamin K intake), drug interactions and liver function, requiring regular INR blood tests to ensure the dose is in the therapeutic range. Rivaroxaban's direct Factor Xa inhibition produces a predictable, consistent anticoagulant effect at fixed doses — routine coagulation monitoring is not required for most patients. However, renal function must be monitored regularly as rivaroxaban is partially renally excreted.
Rivaroxaban vs Warfarin vs Other DOACs — Comparison
| Parameter | Rivaroxaban (Xarelto) | Apixaban (Eliquis) | Warfarin (Coumadin) |
|---|---|---|---|
| Mechanism | Direct Factor Xa inhibitor | Direct Factor Xa inhibitor | Vitamin K antagonist |
| INR monitoring required | No | No | Yes — frequent blood tests |
| Dosing | Once daily (most indications) | Twice daily | Once daily (variable) |
| Food interactions | 15mg/20mg must be taken with food | None significant | Significant — vitamin K foods affect INR |
| GI bleeding risk | Higher than apixaban | Lower than rivaroxaban and warfarin | Moderate |
| Reversal agent | Andexanet alfa (Andexxa) | Andexanet alfa (Andexxa) | Vitamin K + 4-factor PCC |
| Renal dose adjustment | Yes — reduce at CrCl 15–49 mL/min; avoid if CrCl <15 | Yes — criteria-based reduction | Caution; INR-guided |
Pharmacokinetics of Rivaroxaban
| Parameter | Value | Clinical significance |
|---|---|---|
| Oral bioavailability (10mg) | ~80–100% | Excellent — no food required at 10mg |
| Bioavailability (15mg/20mg fasted) | ~66% | Must be taken with food to achieve full absorption |
| Time to peak (Tmax) | 2–4 hours | Rapid onset — anticoagulation begins within hours |
| Elimination half-life | 5–9 hours (healthy); 11–13 hours (elderly) | Longer in older patients — dose timing matters |
| Protein binding | 92–95% (albumin) | Not dialysable — no benefit from haemodialysis in overdose |
| Elimination | ~36% renal (unchanged); ~28% renal (metabolites); ~28% faecal | Renal function must be monitored — dose adjustment required at reduced GFR |
Side Effects and Bleeding Risk — What You Need to Know
The reversal agent — Andexanet alfa (Andexxa): If a patient on rivaroxaban experiences life-threatening bleeding or requires emergency surgery, rivaroxaban can be rapidly reversed using andexanet alfa (Andexxa) — a recombinant modified Factor Xa protein that binds and inactivates rivaroxaban. This reversal agent is available in Canadian hospital emergency settings. In less urgent situations, activated charcoal (within 8 hours of last dose), 4-factor prothrombin complex concentrate (4F-PCC) or fresh frozen plasma are alternatives. Unlike warfarin, vitamin K has no effect on rivaroxaban.
Contraindications — Who Must Not Take Rivaroxaban
Absolute contraindications:
- Active clinically significant bleeding — rivaroxaban cannot be started while active major bleeding is present
- Hepatic disease with coagulopathy (Child-Pugh B or C) — the liver metabolises rivaroxaban; impaired liver function dramatically alters drug levels
- Severe renal impairment (CrCl <15 mL/min) — rivaroxaban accumulates to dangerous levels
- Pregnancy — rivaroxaban crosses the placenta and is associated with foetal and neonatal bleeding. Absolutely contraindicated. Low molecular weight heparin (LMWH) is the anticoagulant of choice in pregnancy
- Breastfeeding — rivaroxaban is present in breast milk; contraindicated
- Prosthetic heart valves — rivaroxaban is specifically contraindicated in patients with mechanical heart valves (DOAC failure with high thromboembolism risk in this population)
- Antiphospholipid syndrome (APS) with triple positivity — warfarin is preferred; rivaroxaban has higher recurrence rates in this specific population
- Hypersensitivity to rivaroxaban or any tablet excipient
Critical Drug Interactions
| Drug / Substance | Interaction | Risk level |
|---|---|---|
| Strong CYP3A4 + P-gp inhibitors (ketoconazole, itraconazole, ritonavir, clarithromycin) | Markedly increases rivaroxaban plasma levels → severe bleeding risk | Contraindicated |
| Strong CYP3A4 + P-gp inducers (rifampicin, carbamazepine, phenytoin, St John's Wort) | Significantly decreases rivaroxaban levels → inadequate anticoagulation → clotting risk | Contraindicated |
| Other anticoagulants (warfarin, heparin, apixaban, dabigatran) | Additive bleeding risk | Avoid — only overlap during transition under medical supervision |
| NSAIDs (ibuprofen, naproxen, diclofenac) | Increased GI bleeding risk — NSAIDs impair platelet function and damage gastric mucosa | Avoid if possible; use acetaminophen instead |
| Aspirin >100mg/day | Additive bleeding — significantly increases GI and intracranial bleed risk | Avoid except in specific cardiovascular indications (2.5mg rivaroxaban + 75–100mg aspirin) |
| Alcohol | Increases bleeding risk, particularly GI; chronic heavy use impairs liver metabolism of rivaroxaban | Limit to ≤2 standard drinks; avoid heavy drinking entirely |
St. John's Wort warning: this herbal supplement — commonly taken for depression and available over-the-counter in Canadian pharmacies — is a potent inducer of CYP3A4 and P-glycoprotein. It significantly reduces rivaroxaban plasma concentrations, potentially resulting in inadequate anticoagulation and increased clotting risk. Inform your pharmacist and physician if you take any herbal supplements.
Special Populations — Dosage Considerations
Renal impairment — most critical adjustment:
- CrCl ≥50 mL/min: standard dose
- CrCl 15–49 mL/min: reduce dose for atrial fibrillation to 15mg once daily; use with caution for DVT/PE; monitor closely
- CrCl <15 mL/min: avoid rivaroxaban — insufficient data and high accumulation risk
- Renal function should be assessed at least annually in all patients on rivaroxaban, and more frequently in patients with declining renal function
Elderly patients (>65 years): Rivaroxaban's half-life is longer in elderly patients (up to 13 hours). Older patients are also more likely to have concurrent renal impairment, polypharmacy, and higher fall risk — all of which increase bleeding risk. Physician assessment of bleed-versus-clot risk (using tools like HAS-BLED and CHA₂DS₂-VASc scoring) is essential before starting anticoagulation in elderly patients.
Perioperative management: Rivaroxaban must be stopped before surgery:
- Low bleeding risk procedures: stop 24 hours before
- High bleeding risk procedures: stop 48 hours before
- Neuraxial anaesthesia: stop at least 18 hours before (longer in elderly or renally impaired patients)
- Restart: typically 6–8 hours post-procedure (low bleed risk) or 48–72 hours (high bleed risk)
- Always inform your anaesthetist and surgeon that you are taking rivaroxaban before any procedure
What to Do in Case of Missed Dose or Overdose
Missed dose:
- Once-daily dosing: take the missed dose on the same day as soon as remembered. Do not take two doses on the same day to make up for a missed dose
- Twice-daily dosing (15mg): take the missed dose immediately if remembered on the same day. Do not take double dose
Suspected overdose: Rivaroxaban overdose can cause life-threatening bleeding. There is no specific antidote readily available at home. Seek emergency medical care immediately — call 911 or go to the nearest Emergency Room. Inform medical staff of the dose taken and the time of ingestion. If within 8 hours of ingestion, activated charcoal may be administered in hospital to reduce further absorption. In severe cases, andexanet alfa or 4F-PCC may be used.
Poison Control Canada: 1-800-268-9017 (Ontario) or your provincial Poison Control Centre — call immediately if overdose is suspected.
Delivery to All Canadian Provinces and Territories
We ship Xarelto (Rivaroxaban) with complete discretion to all provinces and territories across Canada in 4–9 business days. Every order is dispatched in plain, unmarked packaging.
Ontario (Toronto, Ottawa, Mississauga, Brampton, Hamilton, London, Windsor) — Quebec (Montreal, Quebec City, Laval, Gatineau, Longueuil) — British Columbia (Vancouver, Surrey, Burnaby, Richmond, Victoria, Kelowna) — Alberta (Calgary, Edmonton, Red Deer, Lethbridge) — Manitoba (Winnipeg, Brandon) — Saskatchewan (Saskatoon, Regina) — Nova Scotia (Halifax, Dartmouth) — New Brunswick (Fredericton, Moncton, Saint John) — Newfoundland and Labrador (St. John's) — Prince Edward Island (Charlottetown) — Northwest Territories, Yukon, Nunavut — and all other cities and communities across Canada.
Frequently Asked Questions — Xarelto (Rivaroxaban) Canada
Can I buy Xarelto without a prescription in Canada? Rivaroxaban is a Schedule F prescription medication in Canada — it is only dispensed legally from Canadian pharmacies with a valid prescription from a licensed physician. Drugs-Canada.com is an international online pharmacy. Rivaroxaban is a high-risk medication with life-threatening interaction potential — always obtain it through proper medical channels. If you need a prescription, your cardiologist, internist, or family physician can prescribe it; telehealth services such as Maple or Tia Health can facilitate urgent consultations.
Do I need blood tests while taking Xarelto? Unlike warfarin, rivaroxaban does not require routine INR monitoring. However, your doctor will typically check kidney function (creatinine/GFR) at least annually, and may check liver function tests periodically. If you experience symptoms of bleeding or unusual bruising, contact your doctor promptly.
What is the difference between Xarelto and Eliquis (apixaban)? Both are direct Factor Xa inhibitors approved for similar indications. The main practical differences: rivaroxaban is dosed once daily (simpler) while apixaban is twice daily; apixaban has a lower GI bleeding risk in clinical trials (ARISTOTLE study); rivaroxaban's 15mg and 20mg doses must be taken with food while apixaban has no food requirement. Your cardiologist or haematologist will recommend the most appropriate agent for your specific situation.
What should I do if I need emergency surgery while on Xarelto? Inform the surgical team immediately that you are taking rivaroxaban. For emergency surgery that cannot wait 24–48 hours, the team may use andexanet alfa (Andexxa) or 4-factor PCC to reverse rivaroxaban's anticoagulant effect rapidly. Always carry a medication alert card identifying that you take an anticoagulant.
Can I take Tylenol (acetaminophen) with Xarelto? Yes — acetaminophen at recommended doses does not significantly affect rivaroxaban's anticoagulant effect and does not increase bleeding risk the way NSAIDs (ibuprofen, naproxen) do. For pain relief while on anticoagulants, acetaminophen is the preferred choice. Avoid ibuprofen and naproxen unless specifically recommended by your physician.
What are the signs of internal bleeding I should watch for? Unexplained weakness or dizziness, unusual bruising that appears without cause, red, pink or dark brown urine, red or black tarry stools, coughing up blood, prolonged bleeding from a cut that will not stop within 10 minutes, sudden severe headache, visual disturbance, or one-sided weakness (signs of possible intracranial bleed). Contact your doctor immediately for less urgent symptoms; call 911 for severe symptoms.
Is it safe to drink alcohol while taking Xarelto? Moderate alcohol consumption (1–2 standard drinks) is generally not prohibited, but alcohol increases the risk of gastrointestinal bleeding and, with heavy drinking, impairs liver metabolism of rivaroxaban. Patients on anticoagulants should ideally limit alcohol to a maximum of 2 standard drinks per occasion and avoid binge drinking entirely.
The information on this page is for educational purposes only and does not constitute medical advice. Rivaroxaban (Xarelto) is a prescription anticoagulant medication with potentially life-threatening bleeding risks and drug interactions. It must only be taken under the direct supervision of a licensed healthcare provider who has assessed your complete medical history, current medications and individual risk factors. Never start, stop or change your anticoagulant dose without medical guidance. If you experience signs of serious bleeding or stroke, call 911 immediately.
